Gonadorelin
Synthetic gonadotropin-releasing hormone used diagnostically and therapeutically for reproductive hormone assessment and fertility.
Always consult a qualified clinician
This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician
What is Gonadorelin?
Gonadorelin is a synthetic version of the naturally occurring gonadotropin-releasing hormone (GnRH), a decapeptide produced by the hypothalamus. When administered in pulsatile fashion, it stimulates LH and FSH release from the pituitary, supporting natural testosterone and estrogen production. It is used diagnostically to assess pituitary function and therapeutically for hypogonadism and fertility.
Why People Talk About It
Maintaining natural testosterone during TRT alternatives
ModerateFertility preservation
ModeratePituitary function assessment
StrongAlternative to HCG for testicular function
EmergingHow It Works
Gonadorelin is the master reproductive hormone. Given in pulses (like the body naturally does), it tells the pituitary gland to produce LH and FSH, which then stimulate testosterone or estrogen production. It keeps the entire hormone chain working naturally.
Common Questions
Safety Information
Common Side Effects
Cautions
- • Must be administered in pulsatile fashion for stimulatory effect
- • Continuous administration causes receptor desensitization (like leuprolide)
- • Timing and frequency of dosing are critical
What We Don't Know
Well-characterized safety profile for diagnostic use. Long-term therapeutic use data is more limited.
Published Research
32 studiesEffect of 200 µg of gonadorelin at the first gonadotropin-releasing hormone of the Resynch-25 on ovarian dynamics and fertility in lactating Holstein cows
Nerve growth factor from seminal plasma origin (spβ-NGF) increases CL vascularization and level of mRNA expression of steroidogenic enzymes during the early stage of Corpus Luteum development in llamas
Equine chorionic gonadotropin increases fertility of grazing dairy cows that receive fixed-time artificial insemination in the early but not later postpartum period
Fertility of Angus cross beef heifers after GnRH treatment on day 23 and timing of insemination in 14-day CIDR protocol
Fertility of Holstein heifers after two doses of PGF2α in 5-day CO-Synch progesterone-based synchronization protocol
Effects of gonadotropin-releasing hormone administration or a controlled internal drug-releasing insert after timed artificial insemination on pregnancy rates of dairy cows
Effects on normalized testicular atrophy index (TAIn) in cryptorchid infants treated with GnRHa pre and post-operative vs surgery alone: a prospective randomized trial and long-term follow-up on 62 cases
Effect of increasing GnRH and PGF2α dose during Double-Ovsynch on ovulatory response, luteal regression, and fertility of lactating dairy cows
Artificial insemination at 56 h after intravaginal progesterone device removal improved AI pregnancy rate in beef heifers synchronized with five-day CO-Synch + controlled internal drug release (CIDR) protocol
A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol
Effects of one versus two doses of prostaglandin F2alpha on AI pregnancy rates in a 5-day, progesterone-based, CO-Synch protocol in crossbred beef heifers
Pregnancy rates for grade 2 embryos following administration of synthetic GnRH at the time of transfer in embryo-recipient cattle
Unchanged response to stimulation of pituitary hormone release after serial UV irradiation in men
Bioequivalency comparison between two gonadotropin-releasing hormone products
[Value of short-term use of a gonadorelin analog in an in vitro fertilization program]
Estrous synchronization strategies to optimize beef heifer reproductive performance after reproductive tract scoring
Effect of different gonadorelin (GnRH) products used for the first or resynchronized timed artificial insemination on pregnancy rates in postpartum dairy cows
Endometrial expression of progesterone, estrogen, and oxytocin receptors and of 20α-hydroxysteroid dehydrogenase and cyclooxygenase II 2 and 5 days after ovulation in induced short and normal estrous cycles in dairy cows
GnRH dose reduction decreases pituitary LH release and ovulatory response but does not affect corpus luteum (CL) development and function in llamas
Equine chorionic gonadotropin and gonadotropin-releasing hormone enhance fertility in a norgestomet-based, timed artificial insemination protocol in suckled Nelore (Bos indicus) cows
Treatment of cystic ovarian disease in dairy cows with gonadotrophin-releasing hormone: a field study
Prospective case control study to determine the effect of lovastatin on serum testosterone and cortisol concentrations in hyperlipidemic nephrotic patients with chronic renal failure
Efficacy and safety of intravenous pulsatile gonadotropin-releasing hormone: Lutrepulse for injection
[Comparative clinico-therapeutic study of gonadorelin and chorionic gonadotropin in boys with undescended testes]
[Treatment of advanced prostatic cancer with a gonadorelin agonist, dTrp6 LHRH. 41 cases]
Luteinizing hormone-releasing hormone (LHRH) and its analogs for contraception in women: a review
Effect of a GnRH injection on kisspeptin levels in girls with suspected precocious puberty: a randomized-controlled pilot study
The efficacy and safety of rhGH treatment combined with letrozole/GnRHa in adolescent boys
The safety of neoadjuvant hormonal treatment in infants with cryptorchidism
A comparative study of the effects of intramuscular administration of gonadorelin, mating and intrauterine infusion of either raw seminal plasma or seminal plasma purified β-NGF on luteal development in llamas
Effect of gonadorelin, lecirelin, and buserelin on LH surge, ovulation, and progesterone in cattle
Comparison of gonadorelin products in lactating dairy cows: efficacy based on induction of ovulation of an accessory follicle and circulating luteinizing hormone profiles
Always consult a qualified clinician
This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician
Related Peptides
Kisspeptin
ModerateA naturally occurring neuropeptide that plays a central role in reproductive hormone regulation and fertility.
Leuprolide
StrongAn FDA-approved GnRH agonist used for prostate cancer, endometriosis, and precocious puberty through hormonal suppression.
PT-141 (Bremelanotide)
StrongBeginnerAn FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women, also studied for broader sexual dysfunction.
Quick Facts
- Class
- Gonadotropin-Releasing Hormone
- Evidence
- Strong
- Safety
- Well-Studied
- Updated
- Mar 2026
- Citations
- 32PubMed
Also known as
Tags
Related Goals
Evidence Score
Clinical Trials
View Clinical TrialsLinks to ClinicalTrials.gov for reference. Listing does not imply endorsement.
Interested in this peptide? A Noho clinician can help determine if it's right for you.
Talk to a Clinician